PNC Financial Services Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.02M | Buy |
58,856
+465
| +0.8% | +$8.05K | ﹤0.01% | 1179 |
|
2025
Q1 | $1.28M | Buy |
58,391
+238
| +0.4% | +$5.21K | ﹤0.01% | 1072 |
|
2024
Q4 | $1.86M | Sell |
58,153
-309
| -0.5% | -$9.86K | ﹤0.01% | 934 |
|
2024
Q3 | $1.69M | Sell |
58,462
-626
| -1% | -$18.1K | ﹤0.01% | 974 |
|
2024
Q2 | $2.27M | Buy |
59,088
+478
| +0.8% | +$18.3K | ﹤0.01% | 862 |
|
2024
Q1 | $3.45M | Sell |
58,610
-61,175
| -51% | -$3.6M | ﹤0.01% | 742 |
|
2023
Q4 | $7.17M | Buy |
119,785
+45
| +0% | +$2.69K | 0.01% | 564 |
|
2023
Q3 | $4.55M | Sell |
119,740
-2,611
| -2% | -$99.3K | ﹤0.01% | 652 |
|
2023
Q2 | $11.1M | Buy |
122,351
+60,886
| +99% | +$5.55M | 0.01% | 468 |
|
2023
Q1 | $4.05M | Buy |
61,465
+510
| +0.8% | +$33.6K | ﹤0.01% | 689 |
|
2022
Q4 | $3.15M | Buy |
60,955
+3,009
| +5% | +$156K | ﹤0.01% | 748 |
|
2022
Q3 | $3.96M | Buy |
57,946
+194
| +0.3% | +$13.3K | ﹤0.01% | 673 |
|
2022
Q2 | $2.61M | Buy |
57,752
+53
| +0.1% | +$2.4K | ﹤0.01% | 799 |
|
2022
Q1 | $2.93M | Buy |
57,699
+44,751
| +346% | +$2.27M | ﹤0.01% | 821 |
|
2021
Q4 | $612K | Buy |
12,948
+6,890
| +114% | +$326K | ﹤0.01% | 1564 |
|
2021
Q3 | $200K | Buy |
6,058
+110
| +2% | +$3.63K | ﹤0.01% | 2210 |
|
2021
Q2 | $376K | Hold |
5,948
| – | – | ﹤0.01% | 1795 |
|
2021
Q1 | $255K | Hold |
5,948
| – | – | ﹤0.01% | 2026 |
|
2020
Q4 | $340K | Hold |
5,948
| – | – | ﹤0.01% | 1744 |
|
2020
Q3 | $179K | Buy |
5,948
+940
| +19% | +$28.3K | ﹤0.01% | 1999 |
|
2020
Q2 | $164K | Buy |
5,008
+8
| +0.2% | +$262 | ﹤0.01% | 2040 |
|
2020
Q1 | $134K | Hold |
5,000
| – | – | ﹤0.01% | 2043 |
|
2019
Q4 | $154K | Sell |
5,000
-3,760
| -43% | -$116K | ﹤0.01% | 2232 |
|
2019
Q3 | $210K | Sell |
8,760
-1,100
| -11% | -$26.4K | ﹤0.01% | 2103 |
|
2019
Q2 | $251K | Sell |
9,860
-4,280
| -30% | -$109K | ﹤0.01% | 2035 |
|
2019
Q1 | $276K | Buy |
14,140
+4,760
| +51% | +$92.9K | ﹤0.01% | 1952 |
|
2018
Q4 | $124K | Buy |
9,380
+2,440
| +35% | +$32.3K | ﹤0.01% | 2345 |
|
2018
Q3 | $124K | Sell |
6,940
-440
| -6% | -$7.86K | ﹤0.01% | 2465 |
|
2018
Q2 | $162K | Buy |
+7,380
| New | +$162K | ﹤0.01% | 2313 |
|